Search - tctmd.com

Displaying 21 - 36 of 36

Sort: Relevancy | Date

Presentation TCT 2016

Outcome Registries III: 2-Year Results From ASSURE

Presenter: Stephen G. Ellis, Corrado Tamburino, Detlef G. Mathey

October 31, 2016

Presentation TCT 2016

Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First

Presenter: Stephen G. Ellis, Corrado Tamburino, Robert-Jan van Geuns

October 31, 2016

Presentation TCT 2016

Outcome Registries I: Extended Results From ABSORB EXTEND

Presenter: Stephen G. Ellis, Corrado Tamburino, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

ABSORB China Clinical Outcomes at 2 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Runlin Gao

October 31, 2016

Presentation TCT 2016

ABSORB II Clinical Outcomes at 3 Years

Presenter: Stephen G. Ellis, Corrado Tamburino, Bernard R. Chevalier

October 31, 2016

Presentation TCT 2016

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

Presenter: Stephen G. Ellis, Corrado Tamburino, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

Presenter: Antonio L. Bartorelli, Kenneth Chin, Ariel Furer

October 31, 2016

Presentation

1-Year Outcomes With Absorb BVS: Patient-Level, Pooled Meta-Analysis

Presenter: Gregg Stone

March 29, 2016

Presentation JIM 2016

ABSORB BVS:What Have we Learned?

Presenter: Gregg W. Stone

February 09, 2016

Presentation TCT 2015

Comparative Outcomes of Absorb BVS in the Real-world: Insights From GHOST-EU and XIENCE V USA

Presenter: Stephen G. Ellis, Patrick W. Serruys, Davide Capodanno

October 14, 2015

Presentation TCT 2015

TCT 13: Clinical Outcomes After Implantation of Absorb BVS in Small Vessels Results From the Italian RAI Multicenter Registry

Presenter: Stephen G. Ellis, Lorenz Raber, Giulia Masiero

October 13, 2015

Presentation BRS 2014

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Presenter: Roberto Diletti

July 25, 2014

Presentation BRS 2014

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Presenter: Richard J. Rapoza

July 25, 2014

Presentation TCT 2013

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

Presenter: JM White

October 29, 2013

Presentation TCT 2012

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Presenter: Peter Smits

October 23, 2012

Presentation TCT 2012

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

Presenter: Nienke van Ditzhuijzen, Oana Sorop, Mieke van den Heuvel, Jurgen M.R. Ligthart, Karen T. Witberg, Richard van Duin, Ilona Krabbendam-Peters, Douglas Follett, Nagarajan Ramesh, Richard Rapoza, Dirk J. Duncker, Evelyn Regar, Heleen M.M. van Beusekom, Hector M. Garcia-Garcia, Wim J. van der Giessen

January 03, 2012

Advertisement

Outcome Registries III: 2-Year Results From ASSURE

Outcome Registries II: Long-term Outcomes From ABSORB EXPAND and STEMI First

Outcome Registries I: Extended Results From ABSORB EXTEND

ABSORB China Clinical Outcomes at 2 Years

ABSORB II Clinical Outcomes at 3 Years

BVS at the Cusp of Complete Bioresorption: MLD and Vasomotion at 3-years in Absorb and Xience from the ABSORB II trial

TCT 60: Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis From the ABSORB Randomized Trials

1-Year Outcomes With Absorb BVS: Patient-Level, Pooled Meta-Analysis

ABSORB BVS:What Have we Learned?

Comparative Outcomes of Absorb BVS in the Real-world: Insights From GHOST-EU and XIENCE V USA

TCT 13: Clinical Outcomes After Implantation of Absorb BVS in Small Vessels Results From the Italian RAI Multicenter Registry

Outcomes of Clinical Registries with ABSORB BVS:Simple Lesions vs_ Real-World

Perspectives on Polymers and Scaffold Design: Evolution ofAbsorb™ BVS

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

TCT-35. Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3...

Quantitative OCT Analysis of In-stent Neointimal Growth after Implantation of ABSORB™ BVS in a Diabetic Animal Model.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content